Tigecycline Injection Manufacturers India & Pioneer Exporters
Leading Manufacturer, Exporter & Supplier of Tigecycline Injection 50mg (Tygisafe)
Taj Pharmaceuticals Ltd, headquartered in Mumbai and with advanced manufacturing facilities in Vapi, Gujarat, is a well-recognized global leader in the production and supply of Tigecycline Injection 50mg (Tygisafe). Known for our high-quality, purity, and adherence to international manufacturing standards, we serve clients across India, Africa, the Middle East, and Latin America (LTAM), ensuring timely delivery and competitive pricing.
About Tigecycline Injection 50mg (Tygisafe)
Tigecycline is a broad-spectrum glycylcycline antibiotic used for the treatment of serious bacterial infections, including complicated skin and soft tissue infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia. Tigecycline works by inhibiting bacterial protein synthesis, preventing bacterial growth and multiplication.
We manufacture Tygisafe in state-of-the-art WHO-GMP-certified facilities, ensuring stringent quality control from raw material procurement to final packaging.
Therapeutic Indications of Tigecycline Injection
Tigecycline Injection is prescribed for the treatment of:
- Complicated intra-abdominal infections
- Complicated skin and soft tissue infections
- Community-acquired pneumonia
- Infections caused by multi-drug resistant bacteria
- Certain cases of severe bacterial infections and filariasis
Advantages of Choosing Taj Pharma for Tigecycline Injection
- WHO-GMP Certified Manufacturing – Ensures compliance with global pharmaceutical standards.
- High Purity Formulation – Strict quality checks for safety and efficacy.
- Global Supply Chain Network – Timely delivery to domestic and international markets.
- Competitive Pricing – Affordable without compromising on quality.
- Regulatory Support – Complete documentation for registration in multiple countries.
Dosage and Administration
- Strength: Tigecycline Injection 50mg
- Dosage Form: Lyophilized powder for solution for infusion
- Route of Administration: Intravenous (IV) infusion over approximately 30 to 60 minutes
- Recommended Dosage: Initial loading dose of 100 mg, followed by 50 mg every 12 hours
- Treatment Duration: Typically 5 to 14 days, depending on the infection and patient’s clinical response
- Special Precautions: Should be taken on an empty stomach and administered under medical supervision
Precautions and Warnings
- Complete the full prescribed course even if symptoms improve early.
- Avoid use in patients with known hypersensitivity to Tigecycline or tetracycline-class antibiotics.
- Not recommended for children under 8 years due to potential tooth discoloration and effects on bone growth.
- Use with caution in patients with liver impairment—dose adjustments may be necessary.
- May cause dizziness—avoid driving or operating heavy machinery until effects are known.
Possible Side Effects
Like all medicines, Tigecycline may cause side effects. Common reactions include:
- Nausea & vomiting
- Headache
- Diarrhea
- Increased liver enzymes
- Stomach pain
Seek immediate medical attention if you experience:
- Rash, itching, or hives
- Swelling of the face, lips, or tongue
- Difficulty breathing
- Persistent or severe diarrhea
Why Taj Pharma is the Preferred Tigecycline Manufacturer
- Advanced Manufacturing Units in Vapi, Gujarat – Equipped with modern technology for sterile injectable manufacturing.
- Strong Global Footprint – Serving over 40 countries with a consistent supply of Tigecycline Injection.
- Flexible Supply Models – Catering to PCD Pharma Franchise, third-party manufacturing, institutional supply, and tender contracts.
- International Regulatory Compliance – Dossiers available in CTD/eCTD formats for seamless registration.
- PAN India Presence – Efficient distribution network covering all Indian states.
Tigecycline Injection Packaging and Presentation
- Packing: 1 vial of 50mg lyophilized powder with diluent
- Storage: Store at 2°C to 8°C; protect from light
- Shelf Life: 24 months from the date of manufacturing
- Pack Insert: Contains complete prescribing information and safety guidelines
Tigecycline Injection for International Markets
Taj Pharma is a trusted exporter of Tigecycline Injection to multiple global regions:
- Africa – Supplying to public health programs and private hospitals
- Middle East – Partnering with government tenders and distributors
- Latin America – Compliant with local regulatory norms and competitive pricing
- CIS Countries – Timely supply with complete documentation support
Third-Party Manufacturing & PCD Pharma Franchise Opportunities
We offer customized production solutions for Tigecycline Injection 50mg, enabling pharmaceutical companies to market under their own brand name.
- PCD Franchise: Monopoly-based marketing rights in assigned territories
- Third-Party Manufacturing: Bulk production with complete branding support
- Institutional Supply: Hospitals, clinics, and government agencies
Technical Specifications – Tigecycline Injection 50mg (Tygisafe)
| Parameter | Details |
|---|---|
| Product Name | Tigecycline Injection 50mg |
| Brand Name | Tygisafe |
| Strength | 50 mg |
| Dosage Form | Lyophilized powder for solution for infusion |
| Route of Administration | Intravenous infusion |
| Packing | 1 vial + diluent |
| Regulatory Documents | COA, COPP, GMP Certificate, CTD/eCTD Dossier |
| Therapeutic Use | Antibiotic for serious bacterial infections |
| Indication | Intra-abdominal, skin, and pneumonia infections |
| Storage | 2°C – 8°C |
| Dosage | 100 mg loading dose, then 50 mg every 12 hours |
How to Order Tigecycline Injection from Taj Pharma
📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
Tel: +91 – 22 – 2637 4592 / 4593
📠 Fax: +91 – 22 – 2634 1274
Taj Pharma India stands as a pioneer and reliable manufacturer of Tigecycline Injection 50mg (Tygisafe), committed to providing safe, effective, and globally compliant antibiotics. Our focus on quality, affordability, and timely delivery has made us the preferred partner for hospitals, distributors, and government health organizations worldwide.
